The Burden of Invasive Vaccine-Preventable Diseases in Adults in the Middle East and North Africa (MENA) Region

被引:0
作者
Abdul Rahman Bizri
Abdulhakeem Althaqafi
Nawal Kaabi
Nathir Obeidat
Nadine Al Akoury
Hammam Haridy
机构
[1] American University of Beirut Medical Center,Department of Medicine
[2] Ministry of National Guard-Health Affairs,undefined
[3] King Saud bin Abdulaziz University for Health Sciences,undefined
[4] King Abdullah International Medical Research Centre,undefined
[5] Abu Dhabi Health Services Company,undefined
[6] University of Jordan,undefined
[7] Pfizer Inc,undefined
[8] Pfizer Inc,undefined
来源
Infectious Diseases and Therapy | 2021年 / 10卷
关键词
Epidemiology; Invasive bacterial disease; Middle East and North Africa (MENA);
D O I
暂无
中图分类号
学科分类号
摘要
Implementing vaccination programmes at the national level is key to managing vaccine-preventable diseases (VPDs) in the overall population. Although paediatric immunization programmes have significantly reduced the burden of VPD, disease burden in adults still poses a substantial challenge, particularly in low- and middle-income countries such as those within the Middle East and North Africa (MENA) region. Invasive bacterial diseases (IBDs) are an important public health concern within this region, although vaccines are available to prevent the three most common causative organisms associated with IBD: Neisseria meningitidis (NM), Streptococcus pneumoniae (SP), and Haemophilus influenzae (HI). For this review, three separate PubMed searches were used to identify English-language publications describing the epidemiology of NM, SP, and HI in adults within the MENA region. Of the 161 total publications retrieved among all 3 literature searches, 39 were included in this review (NM: 8 publications; SP: 27 publications; HI: 4 publications). Publications describing epidemiology in paediatric or overall populations were excluded. Overall, these studies generally observed a high burden of IBD among adults in this region. Although NM, SP, and HI are communicable diseases in several countries, the surveillance systems in the MENA region are largely inadequate, resulting in poor responses to outbreaks and hindering improvement in outcomes of communicable diseases. Improving IBD surveillance would provide necessary estimates of disease burden, resulting in better vaccination strategies and improved outcomes. In conclusion, the present review provides a summary of the available information on the epidemiology of vaccine-preventable IBD in adults within the MENA region and highlights the need for increased disease surveillance and preventive strategies in these countries.
引用
收藏
页码:663 / 685
页数:22
相关论文
共 242 条
[1]  
Teresa Aguado M(2011)Ten great public health achievements–worldwide, 2001–2010 MMWR Morb Mortal Wkly Rep 60 814-818
[2]  
Barratt J(2018)Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017 Vaccine 36 921-931
[3]  
Beard JR(2015)Adult vaccination Hum Vaccin Immunother 11 150-155
[4]  
Swanson KA(2018)Challenges in adult vaccination Ann Med 50 181-192
[5]  
Schmitt HJ(2016)Recommended immunization schedules for adults: clinical practice guidelines by the ESCMID Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid) Hum Vaccin Immunother 12 1777-1794
[6]  
Jansen KU(2018)Vaccine-preventable diseases in lower-middle-income countries Lancet Infect Dis 18 937-939
[7]  
Anderson AS(2016)Inequalities in full immunization coverage: trends in low- and middle-income countries Bull World Health Organ 94 794-805B
[8]  
de Gomensoro E(2019)Vaccine procurement in the Middle East and North Africa region: challenges and ways of improving program efficiency and fiscal space Vaccine 37 3520-3528
[9]  
Del Giudice G(2018)Breaking the inertia in coverage: mainstreaming under-utilized immunization strategies in the Middle East and North Africa region Vaccine 36 4425-4432
[10]  
Doherty TM(2012)Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention Int J Infect Dis 16 e574-e582